Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening

Prenatal Diagnosis

Volumn 31, Issue 12, 2011, Pages 1153-1159

  Pennings, Jeroen L A ^a   Kuc, Sylwia ^a,b   Rodenburg, Wendy ^a   Koster, Maria P H ^a,b   Schielen, Peter C J I ^a   de Vries, Annemieke ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bioinformatics; Biomarkers; First trimester serum screening; Pre eclampsia

Indexed keywords

BIOLOGICAL MARKER; PLACENTA PROTEIN; PLACENTA PROTEIN 13; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; DISEASE COURSE; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING; TROPHOBLASTIC DISEASE;

BIOLOGICAL MARKERS; DATA MINING; FEMALE; HUMANS; MASS SCREENING; PRE-ECLAMPSIA; PREGNANCY;

EID: 82255162675     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2850     Document Type: Article

References (42)

1. Anderson NL, Polanski M, Pieper R, et al. 2004. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 3: 311-326.
2. Ashburner M, Ball CA, Blake JA, et al. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
3. Aydin S, Benian A, Madazli R, et al. 2004. Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 113: 21-25.
4. Aydin T, Varol FG, Sayin NC. 2006. Third trimester maternal plasma total fibronectin levels in pregnancy-induced hypertension: results of a tertiary center. Clin Appl Thromb Hemost 12: 33-39.
5. Burton GJ, Jauniaux E. 2004. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 11: 342-352.
6. Chaiworapongsa T, Romero R, Yoshimatsu J, et al. 2002. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonatal Med 12: 19-27.
7. Cheng D, Knox C, Young N, et al. 2008. PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res 36: W399-W405.
8. Cnossen JS, Morris RK, Ter Riet G, et al. 2008. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 178: 701-711.
9. Conde-Agudelo A, Villar J, Lindheimer M. 2004. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 104: 1367-1391.
10. Cuckle HS. 2011. Screening for pre-eclampsia--lessons from aneuploidy screening. Placenta 32(Suppl): S42-S48.
11. Dane C, Buyukasik H, Dane B, Yayla M. 2009. Maternal plasma fibronectin and advanced oxidative protein products for the prediction of preeclampsia in high risk pregnancies: a prospective cohort study. Fetal Diagn Ther 26: 189-194.
12. Dolberg Anderson U, Olsson MG, Rutardottir S, et al. 2011. Fetal hemoglobin and alpha(1)-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia. Am J Obstet Gynecol 204: 520.e1520-e1525.
13. Duckitt K, Harrington D. 2005. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330: 565.
14. Eide IP, Isaksen CV, Salvesen KA, et al. 2008. Decidual expression and maternal serum levels of heme oxygenase 1 are increased in pre-eclampsia. Acta Obstet Gynecol Scand 87: 272-279.
15. Jelier R, Schuemie MJ, Veldhoven A, et al. 2008. Anni 2.0: a multipurpose text-mining tool for the life sciences. Genome Biol 9: R96.
16. Kaaja R. 2008. Predictors and risk factors of pre-eclampsia. Minerva Ginecol 60: 421-429.
17. Koster MP, Heetkamp KM, Pennings JL, et al. 2010. Down syndrome screening: imagining the screening test of the future. Expert Rev Mol Diagn 10: 445-457.
18. Krauss T, Kuhn W, Lakoma C, Augustin HG. 1997. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 177: 443-449.
19. Kuc S, Wortelboer EJ, Van Rijn BB, et al. 2011. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 66: 225-239.
20. Lawrence JB, Oxvig C, Overgaard MT, et al. 1999. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96: 3149-3153.
21. Leanos-Miranda A, Marquez-Acosta J, Cardenas-Mondragon GM, et al. 2008. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab 93: 2492-2499.
22. Leeflang MM, Cnossen JS, Van Der Post JA, et al. 2007. Accuracy of fibronectin tests for the prediction of pre-eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 133: 12-19.
23. Liu Y, Kodithuwakku SP, Ng PY, et al. 2010. Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: an in vitro co-culture study. Hum Reprod 25: 479-490.
24. Lorenzi T, Marzioni D, Giannubilo S, et al. 2009. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction. Placenta 30: 35-40.
25. Magnussen EB, Vatten LJ, Lund-Nilsen TI, et al. 2007. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 335: 978.
26. Ness RB, Roberts JM. 1996. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175: 1365-1370.
27. Nishizawa H, Pryor-Koishi K, Suzuki M, et al. 2008. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. Mol Hum Reprod 14: 595-602.
28. Olsson MG, Centlow M, Rutardottir S, et al. 2010. Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia. Free Radic Biol Med 48: 284-291.
29. Pennings JL, Koster MP, Rodenburg W, et al. 2009. Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining. PLoS One 4: e8010.
30. Poon LC, Stratieva V, Piras S, et al. 2010. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13weeks. Prenat Diagn 30: 216-223.
31. Redman CW, Sargent IL. 2005. Latest advances in understanding preeclampsia. Science 308: 1592-1594.
32. Roberts J. 2007. Pre-eclampsia a two-stage disorder: what is the linkage? Are there directed fetal/placental signals? In Pre-eclampsia. Etiology and clinical practice, Lyall F, Belfort M (eds). Cambridge University Press: New York.
33. Roberts JM, Hubel CA. 2009. The two stage model of preeclampsia: variations on the theme. Placenta, 30(Suppl A): S32-S37.
34. Roberts JM, Lain KY. 2002. Recent Insights into the pathogenesis of pre-eclampsia. Placenta 23: 359-372.
35. Sibai B, Dekker G, Kupferminc M. 2005. Pre-eclampsia. Lancet 365: 785-799.
36. Su AI, Wiltshire T, Batalov S, et al. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101: 6062-6067.
37. Vatten LJ, Skjaerven R. 2004. Is pre-eclampsia more than one disease? BJOG 111: 298-302.
38. Visser N, Van Rijn BB, Rijkers GT, et al. 2007. Inflammatory changes in preeclampsia: current understanding of the maternal innate and adaptive immune response. Obstet Gynecol Surv 62: 191-201.
39. WHO. 2005. The World health report: 2005: make every mother and child count. WHO Press: Geneva.
40. Wu C, Orozco C, Boyer J, et al. 2009. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130.
41. Zeisler H, Livingston JC, Schatten C, et al. 2001. Serum levels of adhesion molecules in women with pregnancy-induced hypertension. Wien Klin Wochenschr 113: 588-592.
42. Zumbrunn J, Trueb B. 1996. Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett 398: 187-192.